Overview
Weissenbacher-Zweymuller syndrome (WZS), also known as Pierre Robin syndrome with fetal chondrodysplasia, is a rare congenital skeletal disorder characterized by features present at birth including Pierre Robin sequence (micrognathia, cleft palate, and glossoptosis), rhizomelic limb shortening (shortening of the proximal segments of the limbs), and dumbbell-shaped long bone abnormalities visible on radiographs. The condition primarily affects the skeletal system, craniofacial structures, and in some cases the eyes and ears. Affected neonates may also present with sensorineural hearing loss and myopia. Importantly, the skeletal abnormalities, particularly the limb shortening and vertebral changes, tend to improve significantly with age, and many individuals show normalization of bone structure during childhood. WZS is caused by heterozygous mutations in the COL11A2 gene, which encodes the alpha-2 chain of type XI collagen, a structural protein important for cartilage and bone development. The condition shares clinical overlap with other type XI collagenopathies, including Stickler syndrome type 3 (non-ocular Stickler syndrome) and otospondylomegaepiphyseal dysplasia (OSMED). Some experts consider WZS to be a neonatal presentation that may evolve into one of these related conditions over time. Distinguishing WZS from these overlapping disorders can be challenging and may require long-term clinical follow-up and molecular genetic testing. Treatment is supportive and symptom-based. Neonatal management focuses on addressing airway obstruction and feeding difficulties associated with Pierre Robin sequence, which may require prone positioning, specialized feeding techniques, or in severe cases surgical intervention such as mandibular distraction osteogenesis or tracheostomy. Cleft palate repair is typically performed in infancy. Hearing should be monitored regularly, and hearing aids may be needed for sensorineural hearing loss. Ophthalmologic evaluations are recommended to detect and manage myopia. Orthopedic follow-up is advised, though the skeletal abnormalities generally improve spontaneously. Genetic counseling is recommended for affected families.
Also known as:
Autosomal dominant
Passed on from just one parent; each child has about a 50% chance of inheriting it
Neonatal
Begins at or shortly after birth (first 4 weeks)
Treatments
No FDA-approved treatments are currently listed for Weissenbacher-Zweymuller syndrome.
View clinical trials →Clinical Trials
View all trials with filters →No actively recruiting trials found for Weissenbacher-Zweymuller syndrome at this time.
New trials open frequently. Follow this disease to get notified.
Specialists
View all specialists →No specialists are currently listed for Weissenbacher-Zweymuller syndrome.
Treatment Centers
8 centersBaylor College of Medicine Rare Disease Center ↗
Baylor College of Medicine
📍 Houston, TX
🏥 NORDStanford Medicine Rare Disease Center ↗
Stanford Medicine
📍 Stanford, CA
🔬 UDNNIH Clinical Center Undiagnosed Diseases Program ↗
National Institutes of Health
📍 Bethesda, MD
🔬 UDNUCLA UDN Clinical Site ↗
UCLA Health
📍 Los Angeles, CA
🔬 UDNBaylor College of Medicine UDN Clinical Site ↗
Baylor College of Medicine
📍 Houston, TX
🔬 UDNHarvard/MGH UDN Clinical Site ↗
Massachusetts General Hospital
📍 Boston, MA
🏥 NORDMayo Clinic Center for Individualized Medicine ↗
Mayo Clinic
📍 Rochester, MN
👤 Mayo Clinic Center for Individualized Medicine
🏥 NORDUCLA Rare Disease Day Program ↗
UCLA Health
📍 Los Angeles, CA
Travel Grants
No travel grants are currently matched to Weissenbacher-Zweymuller syndrome.
Community
No community posts yet. Be the first to share your experience with Weissenbacher-Zweymuller syndrome.
Start the conversation →Latest news about Weissenbacher-Zweymuller syndrome
No recent news articles for Weissenbacher-Zweymuller syndrome.
Follow this condition to be notified when news becomes available.
Caregiver Resources
NORD Caregiver Resources
Support, advocacy, and financial assistance for caregivers of rare disease patients.
Mental Health Support
Rare disease caregiving can be isolating. Connect with counseling and peer support.
Family & Caregiver Grants
Financial assistance programs specifically for caregivers of rare disease patients.
Social Security Disability
Learn how rare disease patients may qualify for SSDI/SSI benefits.
Common questions about Weissenbacher-Zweymuller syndrome
What is Weissenbacher-Zweymuller syndrome?
Weissenbacher-Zweymuller syndrome (WZS), also known as Pierre Robin syndrome with fetal chondrodysplasia, is a rare congenital skeletal disorder characterized by features present at birth including Pierre Robin sequence (micrognathia, cleft palate, and glossoptosis), rhizomelic limb shortening (shortening of the proximal segments of the limbs), and dumbbell-shaped long bone abnormalities visible on radiographs. The condition primarily affects the skeletal system, craniofacial structures, and in some cases the eyes and ears. Affected neonates may also present with sensorineural hearing loss and
How is Weissenbacher-Zweymuller syndrome inherited?
Weissenbacher-Zweymuller syndrome follows a autosomal dominant inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.
At what age does Weissenbacher-Zweymuller syndrome typically begin?
Typical onset of Weissenbacher-Zweymuller syndrome is neonatal. Age of onset can vary across affected individuals.